Serial Number
99931365
Owner
Florida State University Board of TrusteesAttorney
Oliver Alan RuizFiling Date
Jul 9, 2026
SUNSHINE GENETICS Trademark
Serial Number: 99931365
Trademark Classes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Westcott Building
Tallahassee, FL 32306-1400
Entity Type: 99
Legal Representation
Correspondence Address
Oliver Alan Ruiz Malloy & Malloy, P.L.
2800 SW 3rd Ave
Miami, FL 33129
United States
Trademark Details
Filing Date
July 9, 2026
Registration Date
Not Registered
Goods & Services
Medical screening; Medical screening services in the field of pediatric rare diseases; Medical testing services; Genetic testing for medical purposes; Medical testing for diagnostic and treatment purposes; Providing information about genetic testing for medical purposes; Medical testing services relating to the diagnosis and treatment of disease; Medical analysis for the diagnosis and treatment of persons; Structural and functional analysis of genomes for medical purposes; Providing educational information about healthcare; Medical testing for diagnostic or treatment purposes in the field of pediatric rare diseases
Medical research; Medical research in the field of rare diseases; Medical research in the field of genetics; Providing information about medical research; Providing medical research information in the field of genetics; Genetic testing for scientific research purposes; Research in the field of genetic diseases; Providing scientific research information in the field of genetics and pediatric rare diseases; Scientific laboratory services in the field of genomics
Promoting public interest and awareness of pediatric rare diseases; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of pediatric rare diseases; Administration of a program for the purpose of screening newborns for medical purposes, namely, the diagnosis and treatment of pediatric rare diseases